Position in IPSC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,299,845
+$4,358,085 QoQ
Shares Held
2,979,529
+128.9% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 98 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. IPSC ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in IPSC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,299,845 | 2,979,529 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,941,760 | 1,301,664 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $453,833 | 456,115 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $221,763 | 445,309 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $212,574 | 380,277 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $461,843 | 970,260 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,001,510 | 991,595 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,655,591 | 968,182 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,385,697 | 935,568 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,134,270 | 510,591 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,555,277 | 468,457 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $929,374 | 464,687 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,401,456 | 443,499 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,461,484 | 421,177 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,101,909 | 409,729 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,797,730 | 383,997 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,379,652 | 283,292 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,372,923 | 267,905 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,415,038 | 215,324 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,150,025 | 204,691 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,134,519 | 38,668 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||